Russell Investments Group
MXCT icon

Russell Investments Group’s MaxCyte MXCT Stock Holding History

Russell Investments Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88K Sell
3,971
-4,405
-53% -$4.39K ﹤0.01% 4042
2026
Q1 		$5.88K Sell
8,376
-630
-7% -$588 ﹤0.01% 3870
2025
Q4 		$14K Sell
9,006
-478
-5% -$764 ﹤0.01% 3716
2025
Q3 		$15K Buy
+9,484
New +$16.5K ﹤0.01% 3681
2024
Q2 		– Sell
-6,700
Closed -$28.1K – 3611
2024
Q1 		$28.1K Buy
+6,700
New +$31.5K ﹤0.01% 2736
2023
Q2 		– Sell
-33,155
Closed -$164K – 3504
2023
Q1 		$164K Buy
+33,155
New +$163K ﹤0.01% 2509

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Russell Investments Group's MXCT Position: Q2 2026 in Review

Russell Investments Group reduced its MaxCyte (MXCT) stake by 53% in Q2 2026, selling an estimated $4.39K and leaving 3,971 shares worth $4.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4042.

Russell Investments Group first reported a position in MXCT in Q1 2023 and has held it in 6 quarters since. The position peaked at $164K in Q1 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Russell Investments Group held 3,971 shares of MaxCyte worth $4.88K as of Q2 2026.
  • Russell Investments Group sold 4,405 MaxCyte shares in Q2 2026, an estimated $4.39K.
  • MaxCyte made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4042 holding.
  • Russell Investments Group first reported a position in MaxCyte in Q1 2023 and has held it in 6 quarters since.
  • Russell Investments Group's MaxCyte position peaked at $164K in Q1 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.